PolyPeptide Group makes peptide-based active pharmaceutical ingredients for the pharmaceutical and biotechnology industries. The company produces custom and generic peptides used in medicines, serving drug developers that need these compounds for their products. It also offers related services around peptide manufacturing and development. PolyPeptide Group is based in Switzerland and runs production facilities in Europe and the United States, supplying customers in the healthcare sector.
PolyPeptide Group AG trades under the code PPGN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #55 of 225 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendStrong
79/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average19.0%
From 52-week high-10.6%
MomentumStrong
78/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return0.9%
6-month return27.2%
12-month, skipping last month78.2%
Stability (higher is calmer)Weak
34/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)44.2%
Worst drawdown, 1 year (smaller is calmer)-24.4%
LiquidityFair
69/100
Moderate trading activity.
See the numbers →
Avg daily value traded4.73M CHF
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 21.80 – 50.10Daily closes, split-adjusted
Signals
50-day average44.03
200-day average37.09
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.22
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
44.05
Bullish
EMA 10
44.06
Bullish
SMA 20
44.05
Bullish
EMA 20
44.05
Bullish
SMA 50
44.03
Bullish
EMA 50
43.84
Bullish
SMA 100
43.39
Bullish
EMA 100
42.26
Bullish
SMA 200
37.09
Bullish
EMA 200
38.32
Bullish
Oscillators (daily)
RSI (14)
55.30
Neutral
MACD (12, 26)
0.01
Bullish
Momentum (12)
0.23
Bullish
Stochastic %K (14)
85.71
Bearish
Williams %R (14)
-14.29
Bearish
CCI (20)
69.18
Neutral
Pivot points (classic, last session)
S3
43.92
S2
43.98
S1
44.07
Pivot
44.13
R1
44.22
R2
44.28
R3
44.37
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 CHF
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.3000
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
